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SUMMARY
mTORC1 controls key processes that regulate cell growth, including mRNA translation, ribosome 
biogenesis and autophagy. Environmental amino acids activate mTORC1 by promoting its 
recruitment to the cytosolic surface of the lysosome, where its kinase is activated downstream of 
growth factor signaling. mTORC1 is brought to the lysosome by the Rag GTPases, which are 
tethered to the lysosomal membrane by Ragulator, a lysosome-bound scaffold. Here, we identify 
c17orf59 as a Ragulator-interacting protein that regulates mTORC1 activity through its interaction 
with Ragulator at the lysosome. The binding of c17orf59 to Ragulator prevents Ragulator 
interaction with the Rag GTPases, both in cells and in vitro, and decreases Rag GTPase lysosomal 
localization. Disruption of the Rag-Ragulator interaction by c17orf59 impairs mTORC1 activation 
by amino acids by preventing mTOR from reaching the lysosome. By disrupting the Rag-
Ragulator interaction to inhibit mTORC1, c17orf59 expression may represent another mechanism 
to modulate nutrient sensing by mTORC1.
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Amino acids induce recruitment of mTORC1 to the lysosomal surface through the Rag GTPases, 
which are tethered to the lysosomal membrane by Ragulator. c17orf59 interacts with Ragulator, 
and overexpression disrupts the Rag-Ragulator complex, preventing Rag lysosomal localization 
and leading to a failure to recruit mTORC1 in the presence of amino acids.
INTRODUCTION
The mechanistic Target of Rapamycin Complex 1 (mTORC1) balances the metabolic state 
of the cell with environmental conditions. mTORC1 positively regulates anabolic processes 
to promote growth, and also controls the availability of the building blocks required for 
these processes by controling catabolic pathways. The anabolic processes regulated by 
mTORC1 include mRNA translation, ribosomal biogenesis, and lipid and nucleotide 
biosynthesis. Autophagy and proteasomal degradation are the major catabolic degradation 
pathways influenced my mTORC1 activity (Laplante and Sabatini, 2012; Zhang et al., 
2014).
Because mTORC1 activity promotes growth processes, which are energy intensive and vital 
for cell division and the functions of terminally differentiated cells, several aspects of 
cellular health control mTORC1 activation. Intracellular conditions, including low energy 
levels, DNA damage, and other stress signals regulate mTORC1, in addition to the 
environmental milieu. Environmental cues that control mTORC1 activity represent the 
general nutritional status of the cell or organism so that mTORC1 is activated by growth 
factors and nutrients, including amino acids and glucose, and is inhibited under hypoxia 
(Zoncu et al., 2011; Shimobayashi and Hall, 2014; Jewell and Guan, 2013; Gomes and 
Blenis, 2015; Zhang et al., 2014).
The mTORC1 pathway integrates different environmental signals by distinct mechanisms, 
well-exemplified by the contrast in pathway activation by growth factors as compared to 
nutrients. Growth factors activate mTORC1 downstream of canonical phosphatidyl 
inositol-3-kinase (PI3K)/Akt signaling. Growth factor-stimulated Akt activates the small 
GTPase Rheb by inhibiting its GTPase activating protein (GAP), tuberous sclerosis complex 
(TSC). GTP-bound Rheb activates the mTOR kinase activity (Tee et al., 2003; Inoki et al., 
2003; Inoki et al., 2002; Garami et al., 2003; Long et al., 2005; Manning et al., 2002; Zhang 
et al., 2003). However, in order for Rheb to control the kinase activity of mTORC1, it must 
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interact with the mTORC1 complex. This interaction is regulated independently of TSC/
Rheb activity, and is controlled by intracellular amino acid and glucose availability (Sancak 
et al., 2008; Sancak et al., 2010; Efeyan et al., 2013; Long et al., 2005 (2); Kim et al., 2008; 
Smith et al., 2005; Hara et al., 1998; Lynch., 2000; Nobukuni et al., 2005). Specifically, 
Rheb resides at the cytosolic face of late endosomal and lysosomal membranes (Menon et 
al., 2014), and mTORC1 localizes to these organelles in an amino acid- and glucose-
dependent manner in order to be activated.
The Rag GTPases regulate mTORC1 localization and recruitment to lysosomes in response 
to intracellular nutrient availability (Sancak et al., 2008; Kim et al., 2008; Sancak et al., 
2010). The Rags are small GTPases encoded by four separate genes (RRAGA, -B, -C, and –
D; coding for RagA, -B, -C, and -D), which form heterodimers in which a single RagA or 
RagB protein is paired with a single RagC or RagD. The Rags localize to the cytoplasmic 
surface of the lysosomal membrane (Sancak et al., 2008; Sancak et al., 2010). Evidence 
suggests that the nucleotide-bound state of each Rag protein in the dimer tends to be 
opposite that of its partner (Sancak et al., 2008). In the absence of amino acids, the RagA/B 
component of the dimer binds GDP and the RagC/D component binds GTP, and the dimer 
does not bind mTORC1 and therefore cannot recruit it to the lysosome. Within minutes of 
the addition of amino acids to the media of starved cells, the nucleotide-bound state is 
reversed such that RagA/B is GTP-bound and RagC/D is GDP-bound, leading to the binding 
and lysosomal recruitment of mTORC1. Expression of “active” Rag dimer mutants where 
RagA or B mimics the GTP-bound state (RagA/BGTP) is sufficient to constitutively localize 
mTORC1 to the lysosomal membrane and activate mTORC1, even in the absence of amino 
acids. Conversely, mTORC1 activity is inhibited by “inactive” Rag mutant dimers 
consisting of RagA/BGDP even when amino acids are present (Sancak et al., 2008; Kim et 
al., 2008).
The Ragulator complex maintains the Rags on the lysosome, and serves as a lysosomal 
docking site for the Rag dimers. Five proteins make up Ragulator: p18, p14, MP1, HBXIP, 
and c7orf59 (Wunderlich et al., 2001; Nada et al., 2009; Sancak et al., 2010; Bar-Peled et 
al., 2012). The complete Ragulator complex is required for mTORC1 activation by amino 
acids and for the appropriate lysosomal localization of the Rags and mTORC1. Loss of any 
component of Ragulator inhibits mTORC1 activation by amino acids and mis-localizes both 
the Rags and mTORC1 away from the lysosomes, even when amino acids are present 
(Sancak et al., 2010; Bar-Peled et al., 2012). Ragulator fulfills two major functions in 
mTORC1 activation: it acts as a scaffold and landing pad for the Rags and mTORC1 at the 
lysosome, and serves as the guanine nucleotide exchange factor (GEF) for RagA and RagB, 
activating the mTORC1 pathway in response to amino acids (Bar-Peled et al., 2012).
In recent years we have searched for novel regulators of the mTORC1 pathway, specifically 
of the amino acid sensing arm. Here, we describe the identification of c17orf59 as a 
Ragulator-interacting protein and its role in the regulation of mTORC1 activation. c17orf59 
binds to Ragulator, but not the Rags, and inhibits the Rag-Ragulator interaction and 
mTORC1 activity when overexpressed. We find that c17orf59 is a component the pathway 
that regulates the nutrient-sensing arm of mTORC1 and represents an alternative mechanism 
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to inhibit mTORC1 via disruption of the interaction between the Rag GTPases and 
Ragulator.
RESULTS
c17orf59 interacts with Ragulator but not the Rag GTPases
In order to identify proteins that may play a role in the amino sensing pathway upstream of 
mTORC1, we used immunoprecipitation of epitope-tagged Ragulator components followed 
by mass spectrometry (IP/MS). Immunoprecipitation of the FLAG-tagged, stably-expressed 
Ragulator subunit HBXIP specifically yielded peptides corresponding to c17orf59 in 
addition to the Rag GTPases and other known members of Ragulator complex (Figure 1A). 
Consistent with this finding, mass spectrometric analysis of immunoprecipitates of stably-
expressed, epitope-tagged c17orf59 contained peptides corresponding to all Ragulator 
subunits, including p18, p14, MP1, HBXIP, and c7orf59. Interestingly, no peptides were 
identified corresponding to any Rag protein, suggesting that c17orf59 only interacts with 
Ragulator (Figure 1A).
To confirm the mass spectrometry data, we analyzed immunoprecipitates of c17orf59, 
Ragulator, and the Rags by western blotting. Stably-expressed, epitope-tagged c17orf59 co-
immunoprecipitated all subunits of Ragulator, to levels comparable with epitope-tagged p14 
(Figure 1B). While, as expected, p14 interacted with RagA and RagC, c17orf59 did not co-
immunoprecipitate either Rag GTPase (Figure 1B). In reciprocal immunoprecipitations, 
epitope-tagged RagB co-immunoprecipitated Ragulator subunits, but not c17orf59 (Figure 
1C).
We used in vitro binding assays to test whether c17orf59 binds directly to Ragulator, as 
opposed to an indirect interaction that depends on other proteins or components of the cell. 
In these assays, purified Ragulator bound c17orf59 (Figure 1D). Purified Rags failed to 
interact with purified c17orf59, even when Ragulator was present (Figure 1D). This 
confirms that c17orf59 likely interacts directly with members of Ragulator and that the Rags 
do not interact with c17orf59.
c17orf59 localizes to the lysosome along with Ragulator
Ragulator localizes to lysosomes and late endosomes by virtue of lipid modifications and 
targeting sequences on the N-terminus of p18 (Sancak et al., 2010, Nada et al., 2009). 
Consistent with its interaction with Ragulator, HA-tagged c17orf59 co-localizes with the 
lysosomal marker LAMP2 (Figure 2A) indicating its presence at lysosomes. To determine 
the extent of co-localization between c17orf59 and Ragulator, we re-expressed the cDNA 
for p18 in p18-null MEFs and examined the localization of c17orf59 and p18. Cells 
expressing HA-tagged c17orf59 display a highly significant co-localization with p18 (Figure 
2B, Supplemental Figure 1A and 1B). c17orf59 also co-localizes with another Ragulator 
subunit, LAMTOR4, in a p18-dependent manner (Supplemental Figure 1C), further 
supporting the existence of a c17orf59-Ragulator interaction. The subcellular localization of 
c17orf59 was unaffected by the presence or absence of amino acids or insulin (Figure 2C 
and 2D).
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c17orf59 loss does not alter mTORC1 activity in response to amino acids or insulin
To examine the effects of loss of c17orf59 on mTORC1 activation, we generated c17orf59-
null HEK-293E and HeLa cells using the sgRNA/Cas9 system and reconstituted c17orf59 
with expression of its cDNA driven by the c17orf59 promoter. The c17orf59-null cells 
showed no signaling defects in response to amino acid or serum starvation and re-
stimulation, as compared to non-targeting sgRNA or c17orf59-null cells reconstituted with 
c17orf59 (Figure 3A and 3B, Supplemental Figure 2A and 2B), even when intermediate 
doses of either amino acids or insulin were added back to cells (Supplemental Figure 2C and 
2D). In addition, c17orf59 null cells had no alterations in mTORC1 signaling in response to 
cholesterol deprivation, the only known stimulus that alters c17orf59 expression (Bartz et 
al., 2009) (Supplemental Figure 2E). Despite its interaction with Ragulator, loss of c17orf59 
does not cause alterations in mTORC1 activation by amino acids or insulin. This lack of 
signaling phenotype was consistent across multiple clones of c17orf59-null cells using 
multiple guides in both HEK-293E and HeLa cells, as well as using shRNA-mediated 
knockdown of c17orf59 (data not shown), so we are confident that the results are not the 
product of re-wiring in the single cell clones that became the c17orf59-null cells. Based on 
these results, we tested the effects of c17orf59 overexpression on Ragulator function and 
mTORC1 activity.
c17orf59 disrupts the Rag-Ragulator interaction in cells and in vitro
The interaction between c17orf59 and Ragulator, but not the Rags, implies that there is a 
subset of the cellular pool of Ragulator that does not interact with the Rags. As some of this 
pool interacts with c17orf59, it is possible that increasing the amount of the c17orf59-
Ragulator complex could lead to the loss of the Rag-Ragulator interaction by titrating away 
Ragulator from the Rags. We tested this hypothesis by overexpressing c17orf59 transiently 
in cells expressing either FLAG-tagged p14 or RagB.
As expected, Ragulator subunits p18 and p14 both co-immunoprecipitated with purified 
FLAG-tagged RagA when a control protein (Methionine aminopeptidase 2, Metap2) was 
overexpressed. As expected, Raptor, the defining subunit of mTORC1, also co-
immunoprecipitated with FLAG-RagA. However, overexpression of c17orf59 disrupted the 
Rag-Ragulator complex so that RagA no longer co-immunoprecipitated p18, p14, or Raptor 
to the same extent, indicating a loss of binding to both Ragulator and mTORC1 (Figure 4A). 
Conversely, immunoprecipitated Ragulator interacted with RagA and RagC, as well as 
Raptor, but these interactions diminished upon c17orf59 overexpression (Figure 4B).
To examine if c17orf59 can alter the Rag-Ragulator interaction in a cell-free setting, we 
used in vitro binding assays with purified proteins. Much like in cells, when purified 
c17orf59 was pre-incubated with the GST-Ragulator, there was a dose-dependent decrease 
in the amount of purified Rags that bound to immobilized Ragulator (Figure 4C). In a 
similar experiment using immobilized, GST-tagged RagB with RagC, increasing amounts of 
purified c17orf59 decreased Ragulator binding to the Rags (Figure 4D).
Because Ragulator is required for the lysosomal localization of the Rag GTPases, it is 
possible that the disruption of the Rag-Ragulator interaction due to c17orf59 overexpression 
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results in a mis-localization of the Rag GTPases away from the lysosome. To test this, we 
transiently expressed FLAG-tagged c17orf59 in HEK-293T cells, marking cells that were 
transfected using GFP driven by an internal ribosome entry sequence (IRES) downstream of 
the c17orf59 cDNA. The amount of RagC that co-localizes with the lysosomal marker 
LAMP1 decreases in cells that overexpress c17orf59, but not FLAG-tagged GFP alone 
(Figure 4E, GFP-positive cells). Importantly, overexpression of c17orf59 does not alter the 
localization of Ragulator component LAMTOR4 (Supplemental Figure 3A) indicating that 
Ragulator is still intact and present at lysosomes.
In summary, c17orf59 disrupts the Rag-Ragulator complex in cells as well as in vitro 
resulting in a reduction in the lysosomal localization of the Rag GTPases. In vitro binding of 
either Rags or c17orf59 to Ragulator implies that c17orf59 has the ability to directly 
compete with the Rags for binding to Ragulator, producing a Rag- and mTORC1-free 
Ragulator-c17orf59 complex.
c17orf59 overexpression inhibits mTORC1
We hypothesized that because c17orf59 can disrupt the Rag-Ragulator interaction and RagC 
localization, c17orf59 overexpression would inhibit mTORC1 activation by amino acids. 
Indeed, overexpression of c17orf59 produced a dose-dependent inhibition of mTORC1 
activation in response to amino acid stimulation, to a level comparable to the inhibition 
produced by dominant-negative RagBGDP expression (Figure 5A).
To confirm that overexpression of c17orf59 inhibits mTORC1 through the nutrient sensing 
machinery and through the disruption of the Rag-Ragulator interaction, we examined mTOR 
localization in cells that overexpress c17orf59. Using the FLAG-c17orf59-IRES-GFP 
construct described above, mTOR remained largely diffuse upon stimulation with amino 
acids in c17orf59-expressing HEK-293T cells (Figure 5B, GFP-positive cells in the top 
panel). mTOR localizes to lysosomes in control cells that either were not transfected or 
expressed FLAG-GFP alone (Figure 5B, GFP-negative cells in the top panel or GFP-
positive cells in the bottom panel).
If the c17orf59 overexpression-mediated disruption of the Rag-Ragulator interaction 
represents the mechanism of mTORC1 inhibition by c17orf59, overexpression of c17orf59 
should inhibit mTORC1 even in cells that express the dominant-active RagBGTP mutant. 
Under normal conditions, dominant-active RagBGTP constitutively recruits mTORC1 to the 
lysosome. The interaction between Rags and Ragulator is required to bring mTORC1 to the 
lysosome; disruption of the Rag-Ragulator complex by c17orf59 would act in an epistatic 
nature to the normally activating effect of RagBGTP. Without Rag binding to Ragulator, the 
Rag mTORC1 will not be recruited to the lysosome.
We overexpressed c17orf59 in cells stably expressing RagBQ99L, the RagBGTP mutant, or a 
control protein, Metap2. Overexpression of c17orf59 diminished phosphorylation of S6K1 
in a dose-dependent manner in both constitutively active, RagBGTP-expressing and control 
cells (Figure 5C), indicating that c17orf59 overexpression inhibits mTORC1 signaling even 
in the presence of the active Rags, likely due to the loss of lysosomal Rag localization.
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DISCUSSION
We find that c17orf59 is a Ragulator-interacting protein. c17orf59 interacts with Ragulator 
in a manner that competes with the Rag GTPases for binding, both in cells and in vitro. Loss 
of the Rag-Ragulator interaction due to c17orf59 overexpression decreases binding between 
the Rags and mTORC1 as well as Ragulator and mTORC1 and prevents both the Rags and 
mTORC1 from binding to the lysosomal membrane. Concomitant to the loss of the 
Ragulator-Rag-mTORC1 interactions, overexpression of c17orf59 inhibits mTORC1 
activity in response to amino acid availability. RagAGTP expression, which normally 
induces constitutively active amino acid signaling by maintaining mTORC1 on the 
lysosome, is not sufficient to rescue the signaling defect downstream of c17orf59 
overexpression, indicating that high levels of c17or59 prevent productive interactions 
between the Rags, Ragulator and mTORC1 in a Rag nucleotide state-independent manner, 
likely by preventing the Rags from localizing to the lysosome.
Identifying and characterizing proteins that interact with Ragulator or other components of 
the amino acid-sensitive mTORC1 signaling pathway is important for understanding how 
eukaryotic cells sense amino acids and other nutrients that regulate mTORC1. Ragulator was 
originally described as the lysosomal scaffold for the Rags (Sancak et al., 2010) and upon 
identification of additional components of the Ragulator (HBXIP and c7orf59) we found 
that the scaffold also acts as a GEF for the Rags (Bar-Peled et al., 2012). It is likely that as 
more Ragulator-interacting proteins are uncovered, additional ways that Ragulator can 
control mTORC1 will be found; here c17orf59 competes with the Rags to bind Ragulator.
c17orf59-mediated inhibition of the Rag-Ragulator interaction represents an alternative 
mechanism of mTORC1 inhibition. Potential negative regulators of the amino acid sensing 
pathway have been reported to act directly upon the Rag GTPases or their regulatory 
proteins to alter their nucleotide-bound state (e.g. GATOR [Bar-Peled et al., 2013; Panchaud 
et al., 2013], Sestrins [Parmigiani et al., 2014; Chantranupong et al., 2014; Peng et al., 
2014], Leucyl-tRNA synthetase [Han et al., 2012; Bonfils et al., 2012], SH3BP4 [Kim et al., 
2012]). Interestingly, the mechanism of mTORC1 inhibition by c17orf59 is independent of 
the Rag nucleotide-bound state, implying that regardless of the presence of nutrients, 
c17orf59 can inhibit the Rag-mTORC1 interaction and prevent mTORC1 from being 
activated by Rheb.
The disruption of the Rag-Ragulator interaction by c17orf59 also suggests the possibility for 
the design of a new mTORC1 inhibitor. That c17orf59 can prevent the Rags from binding to 
Ragulator in vitro, as well as in cells, implies that the binding site between the two 
complexes is an accessible surface that could be the target of a small molecule or peptide. A 
molecule that mimics the presence of c17orf59 could provide an mTORC1-specific inhibitor 
that inhibits mTORC1 completely without affecting mTORC2. An inhibitor of only 
mTORC1 would be a useful research tool to determine the distinct functions of the complex 
in cells. Currently, mTOR kinase inhibitors target both mTORC1 and mTORC2 by virtue of 
the shared kinase between the two complexes (Thoreen et al., 2009; Feldman and Shokat, 
2010) and rapamycin, which was originally thought to be mTORC1-specific, is a 
compromised tool to interrogate mTORC1 activity because it only partially inhibits 
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mTORC1 and can inhibit mTORC2 assembly upon prolonged treatment (Thoreen et al., 
2009; Feldman et al., 2009; Sarbassov et al., 2006). Peptides derived from c17orf59 could 
potentially inhibit mTORC1; alternatively a small molecule that binds to the same, 
accessible surface on the structure of Ragulator that c17orf59 and, likely, the Rags bind to 
could be an effective mTORC1 inhibitor.
The binding of c17orf59 to the Ragulator in a Rag-independent manner and the inhibition of 
mTORC1 activity by c17orf59 overexpression suggest that c17orf59 is a negative regulator 
of the nutrient-sensing pathway. However, loss of c17orf59 did not result in detectable 
defects in mTORC1 signaling in response to starvation of or re-stimulation by amino acids 
or insulin in HEK-293E and HeLa cell lines. c17orf59-null cells also displayed no 
alterations in the inhibition of mTORC1 by cholesterol deprivation, the only reported 
regulator of c17orf59 expression. It is possible that other conditions may inhibit mTORC1 in 
a manner that depends on either an increase in c17orf59 expression or promotes c17orf59 
binding to Ragulator.
c17orf59 is present in and binds to Ragulator in the cell lines used in this work, however, it 
is possible that there are cell types that express c17orf59 at a higher level, which would 
allow for greater levels of binding and inhibition of mTORC1 and might manifest stronger 
response to c17orf59 loss or perturbation.
It is also possible that c17orf59 is not a negative regulator of the mTORC1 pathway, but 
rather that the c17orf59-Ragulator complex has mTORC1-independent functions. c17orf59 
could have a role in a different, unidentified pathway that also utilizes Ragulator. If this 
were the case, Ragulator would have mTORC1-independent functions when bound to 
c17orf59 and not the Rags. This would not be completely unprecedented, as other 
components of the nutrient-sensing pathway serve other functions in the cell. We have 
previously shown that the v-ATPase is a Ragulator-binding complex that regulates 
mTORC1 signaling but also functions as a major proton pump to maintain the acidic nature 
of the lysosome as well as other organelles, and that the maintenance of pH may be de-
coupled from the role of the v-ATPase in mTORC1 activation (Zoncu et al., 2011). 
Similarly, GATOR2, which acts is upstream of the GAP for RagA and B (GATOR1) and is 
required for amino acid signaling to mTORC1, includes Sec13 and Seh1L (Bar-Peled et al., 
2013), which serve multiple other functions in the cell. Sec13 is a COPII component 
required for the generation of vesicles that traffic from the endoplasmic reticulum and Golgi 
and also participates in the nuclear pore complex (Devos et al., 2004; Gurkan et al., 2006; 
Brohawn et al., 2009). Seh1L is also a component of the nuclear pore complex, where it 
binds directly to Sec13 (Brohawn et al., 2009).
One potential function for the c17orf59-Ragulator complex could be the recently described 
BLOC-1-related complex (BORC), which contains c17orf59 and controls lysosomal 
positioning (Pu et al., 2015). It is unclear how the assembly of BORC is regulated within the 
cell or if this complex regulates mTORC1, but the authors imply that Ragulator interacts 
with BORC subunits (Pu et al., 2015), which would indicate a role for the c17orf59-
Ragulator complex in lysosomal positioning as a part of BORC. This is consistent with 
literature that Ragulator components are important for maintaining endolysosomal 
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morphology and biogenesis (Teis et al., 2006; Nada et al., 2009; Takahashi et al., 2012; 
Vogel et al., 2015) and consistent with our observed alterations in lysosomal staining in cells 
that overexpress c17orf59 (Figure 4E and Figure 5B). It is possible that Ragulator binds to 
c17orf59 and BORC in a Rag- and mTORC1-independent manner to control endosome and 
lysosome morphology.
Cholesterol deprivation has been shown to cause a mild increase in c17orf59 expression in 
the only previously reported regulation or function of c17orf59 (Bartz et al., 2009). When 
we deprived cells of cholesterol, we saw a mild upregulation of c17orf59 at the protein level, 
in accordance with the previously reported regulation of c17orf59, potentially by the Sterol 
Responsive Element Binding Protein (SREBP) (Bartz et al., 2009).
It remains to be determined if c17orf59 is indeed a negative regulator of the nutrient-sensing 
pathway, or if it is a component of a Ragulator-containing pathway that acts independently 
of mTORC1. Regardless of the physiological role of c17orf59 in the cell, we have 
uncovered an additional cellular mechanism for mTORC1-specific inhibition, namely by 
altering the Rag-Ragulator interaction.
MATERIALS AND METHODS
Reagents
The following antibodies were obtained from Cell Signaling Technologies (CST): antibodies 
against Phospho-T389-S6K (#9206 and #9205), S6K1 (9202 and 2708), mTOR (#293), 
c7orf59/LAMTOR4 (#12284 for blotting; #13140 for immunofluorescence), p18 (#8975), 
MP1 (#8168), p14 (#8145), HBXIP (#14633), RagA (#4357), RagC (#3360), FLAG epitope 
(2368), and HA epitope (#2367 and #3724). Antibodies against Raptor (Millipore #09-217), 
FLAG (Sigma #F1804), LAMP1 (Developmental Studies Hybridoma Bank at the University 
of Iowa # 1D4B), LAMP2 (Santa Cruz Biotechnology #18822) and Actin (Sigma #A5441) 
were obtained elsewhere. The antibody to c17orf59 was a generous gift from Jianxin Xie at 
CST.
Inactivated Fetal Bovine Serum (IFS), RPMI, and DMEM were obtained from US 
Biologicals. Amino acids for re-stimulation experiments were purchased from Sigma and 
dissolved in water to a concentration of 10x compared to the RPMI amino acid 
concentrations, as described previously (Sancak et al., 2008).
Cell lysis and immunoprecipitation
Cells were washed once with ice-cold PBS and lysed with CHAPS lysis buffer (0.3% 
CHAPS [Sigma #C3023], 10 mM beta-glycerol phosphate [Sigma #G9422], 10mM sodium 
pyrophosphate [Sigma #221368], 40mM HEPES [pH 7.4], and 2.5 mM MgCl2) with one 
tablet of EDTA-free protease inhibitor (Roche #11 873 580 001) per 25 ml. Lysates were 
cleared by centrifugation at 13,000 rpm in a table-top microcentrifuge for 10 minutes. For 
anti-FLAG immunoprecipitations, cleared lysates were normalized for protein content by 
Bradford assay (Bio-Rad #500-0006) and incubated for 1.5-3 hours with 30 μl of 50% slurry 
of FLAG-M2 affinity gel (Sigma #A2220) that had been washed three times in lysis buffer. 
After incubation, beads were washed three times with lysis buffer containing 150 mM NaCl.
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Immunoprecipitated proteins were denatured by the addition of 35 μl of sample buffer and 
boiling for 5 minutes. In experiments using only cell lysates, without immunoprecipitation, 
1% Triton X-100 (Sigma T9284) was substituted for CHAPS in the lysis buffer.
In transfection experiments in which epitope-tagged proteins were immunoprecipitated, 2 
million HEK-293T cells were seed in 10 cm culture dishes. 24 hours later 500 ng of each 
pRK5-based plasmids was transfected using X-tremeGENE9 (Roche #06 365 809 001) 
according to the manufacturers protocol: FLAG-Metap2, FLAG-p14/HA-MP1, FLAG-
c17orf59, FLAG-RagB/HA-RagC. Empty pRK5 vector was used to normalize total plasmid 
amount to 2 μg per 10 cm culture dish. Thirty-six hours after transfection, cells were lysed in 
1 ml lysis buffer as described above.
For experiments in which c17orf59 was expressed with Rag or Ragulator components, 2 
million HEK-293T cells were seeded in 10cm culture dishes. Twenty-four hours later, the 
following pRK5-based plasmids were transfected using X-tremeGENE9: 100 ng of each 
FLAG-Metap2, FLAG-p14 with HA-MP1, FLAG-RagB with HA-RagC co-transfected with 
1 μg of either HA-c17orf59 or HA-Metap2. Thirty-six hours after transfection, cells were 
lysed in CHAPS lysis buffer as described above.
For experiments where cells were starved and re-stimulated with amino acids or insulin, 
400,000 HEK-293E cells were seeded in 6-well plates coated with fibronectin (Millipore 
#341635). Forty-eight hours later, cells were washed once with PBS or starvation media and 
incubated in RPMI lacking all amino acids (US Biological # R9010) supplemented with 5% 
dialyzed IFS for one hour or in DMEM without serum for 3 hours and stimulated with 
amino acids or insulin (100 ng/ml; Sigma # I2643) for 10 minutes. Cells were lysed as 
described above in 130 μl Triton lysis buffer. Alternatively, 500,000 HeLa cells were seeded 
in 6-well plates and starved, re-stimulated and lysed as described above after culturing 
overnight.
For dialysis, 100 ml IFS was dialyzed in SnakeSkin Dialysis Tubing with a 3.5 kDa cutoff 
(Thermo #PI88244) against approximately 3L PBS at 4°C for 48 hours, replacing with fresh 
PBS after 24 hours.
c17orf59 overexpression in signaling experiments
In experiments where mTORC1 activity was assessed upon overexpression of c17orf59, 
FLAG-S6K1 co-expression and immunoprecipitation was used as described previously 
(Bar-Peled et al., 2012). Briefly, 2 million HEK-293T cells were seeded in 10 cm culture 
dishes. 24 hours later, 2 μg of the cDNA for a control protein, HA-Metap2, 200 ng HA-
RagB-T54N (RagBGDP) or between 500 ng and 2 μg of the cDNA for HA-c17orf59 was co-
transfected into HEK-293T cells with 2 ng of the cDNA for FLAG-S6K1. Empty pRK5 
vector was used to normalize total plasmid amount to 2 μg per 10 cm plate. 36 hours post-
transfection, cells were starved of amino acids, stimulated with amino acids and lysed and 
FLAG-S6K1 was immunoprecipitated as described above.
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Mass spectrometry
Immunoprecipitates from nearly confluent 15 cm culture dishes containing HEK-293T cells 
stably expressing FLAG-Metap2, FLAG-HBXIP, or FLAG-c17orf59 were prepared using 
CHAPS lysis as described above, except 50 μl of FLAG-M2 affinity gel was used for 
immunoprecipitations and beads were washed 6 times in lysis buffer containing 150mM 
NaCl. Bound proteins were eluted from the FLAG-M2 affinity gel by incubation in 50μl 
1mg/ml FLAG-peptide (sequence DYKDDDK) for 45 minutes on ice and denatured by 
addition of loading buffer and boiling for 5 minutes. Samples were resolved on 4-12% 
NuPage gels (Life Technologies) and stained with SimplyBlue SafeStain (Life Technologies 
LC6065). Each lane was cut into 10 pieces and digested in trypsin overnight. Resulting 
digests were analyzed at the Whitehead Institute Proteomics core using a Thermo Fisher 
LTQ with Waters NanoAcuity UPLC mass spectrometer. Data were analyzed using Scaffold 
Free Viewer (Proteome Software).
In vitro binding
Purification of recombinant proteins and in vitro binding assays using GST-tagged Rag 
GTPases or Ragulator were done as described (Bar Peled et al., 2012). Briefly, 4 million 
HEK-293T cells were seeded in 15cm culture dishes. Forty-eight hours after seeding, cells 
were transfected with cDNA for the following genes using PEI (Polysciences #23966; 3 μl 
PEI at 1 mg/ml per μg DNA): for HA-GST-Ragulator: 4 μg HA-GST-p14, 8 μg HA-MP1, 8 
μg p18G2A-FLAG (a lipidation defective mutant), 8 μg HA-HBXIP, and 8 μg HA-c7orf59; 
for FLAG-Ragulator: 4 μg p18G2A-FLAG, 8 μg HA-MP1, 8 μg HA-p14, 8 μg HA-HBXIP, 
and 8 μg c7orf59; for HA-GST-Rag GTPases: 8 μg HA-GST-RagB, 16 μg HA-RagC; for 
FLAG-Rag GTPases: 8 μg FLAG-RagB, 16 μg HA-RagC; for individual proteins: 10 μg 
FLAG-c17orf59; 10 μg FLAG-Rap2a; 10 μg HA-GST-Rap2a.
Thirty-six hours after transfection, cells were lysed as described above, using 750 μl Triton 
lysis buffer per dish. After clearing the lysates, 50 μl of 50% slurry of FLAG-M2 affinity 
resin in lysis buffer or 200 μl of 50% slurry of immobilized glutathione affinity resin 
(Thermo #15160) in lysis buffer were added to lysates expressing FLAG- or GST-tagged 
proteins, respectively. Recombinant proteins were incubated with affinity resin for 2 hours 
at 4°C with rotation. Each sample was washed once in lysis buffer, five times in wash buffer 
(0.3% CHAPS, 2.5 mM MgCl2, 40 mM HEPES, 500 mM NaCl) and three times in binding 
buffer (0.3% CHAPS, 2.5 mM MgCl2, 40 mM HEPES). GST-tagged samples were re-
suspended in 160 μl binding buffer and FLAG-tagged samples were eluted in 50 μl FLAG-
peptide in binding buffer. When necessary, eluates were concentrated using centrifugal 
filters with a 10 kDa cutoff (Millipore #UFC501024).
For the initial binding reactions, 20 μl of glutathione affinity resin containing immobilized 
HA-GST-tagged proteins was incubated in binding buffer supplemented with 2 mM DTT 
and 1 mg/mL BSA (NEB #B9000) with 745 ng (20 pmol) FLAG-c17orf59 or 1.5 μg (20 
pmol) FLAG-Ragulator to a final volume of 50 ul for 90 minutes on ice. To terminate 
binding assays, samples were washed three times with 1 ml of ice-cold binding buffer 
supplemented with 150 mM NaCl followed by the addition of 50 μl sample buffer.
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Binding assays in which increasing amounts of c17orf59 were added to GST-tagged 
Ragulator or Rag GTPases were done as described above, except that FLAG-c17orf59 was 
incubated with FLAG-Ragulator for 30 minutes prior to the incubation with other proteins 
on ice. For experiments where FLAG-c17orf59 was added to GST-Ragulator, 100 ng-10 μg 
(2.7 pmol-270 pmol) was incubated with Ragulator and 2 μg (25 pmol) Flag Rags were 
added to the reaction for 90 minutes. For experiments where FLAG-c17orf59 was added to 
GST-Rags, 100 ng-2 μg (2.7 pmol-270 pmol) was incubated with 1μg (14 pmol) FLAG-
Ragulator for 30 minutes prior to addition to GST-Rag GTPases.
Immunofluorescence
1.5 million p53-null MEFs were transfected with 20 ng HA-c17orf59 and 1 μg empty pRK5 
using the MEF Nucleofector kit 1 (Lonza #VPD-1004) using a nucleofector (Lonza) and 
seeded onto fibronectin-coated glass cover slips. Two wells of a 6-well culture dish were 
seeded per 1.5 million MEFs transfected. The following day, cells were either left untreated 
or starved and re-stimulated of amino acids or insulin as described above. Slides were fixed 
and processed as described previously (Zoncu et al., 2011). Briefly the slides were rinsed 
once with PBS and fixed using 4% paraformaldehyde in PBS for 15 minutes. Slides were 
washed twice with PBS and permeabilized with 0.05% Triton X-100 in PBS for 15 minutes. 
Slides were washed three times in PBS and incubated with primary antibody in 5% normal 
donkey serum (Jackson #017-000-121) for 1 hr at room temperature (1:300 for anti-LAMP1 
antibody and 1:150 for anti-HA antibody), washed three times with PBS, and incubated with 
secondary antibodies produced in donkey (diluted 1:500 in 5% normal donkey serum) for 45 
min at room temperature in the dark, and washed three times with PBS. Slides were 
mounted on glass coverslips using ProLong Diamond Antifade Mountant (Molecular Probes 
#P36966) and imaged on a spinning disk confocal system (Perkin Elmer).
p18-/- MEFs were transfected, treated and fixed as above. Samples were washed three times 
in PBS and blocked for 1 hour in 5% normal donkey serum in PBS containing 0.3% Triton. 
Samples were incubated in primary antibodies diluted in 1% BSA in PBS containing 0.3% 
Triton overnight in a humidified chamber at 4degC. Primary antibodies used were as 
follows: anti-LAMP1 (diluted 1:200), anti-HA (diluted 1:100), p18 (diluted 1:100) and 
LAMTOR4 (diluted 1:800) The next day samples were washed with PBS three times and 
incubated for 1-2 hours at room temperature with Alexa Fluor-conjugated secondary 
antibodies (Molecular Probes, diluted 1:500). Samples were then washed two times with 
PBS and incubated with Hoechst 33342 (Molecular probes H3570, 1:10,000) in PBS for 15 
seconds and washed twice in PBS. Cover slips were mounted on glass slides with 
Vectashield Mounting Media and cured overnight at room temperature and then imaged as 
described above.
Alternatively, HEK-293T cells were transfected with 1 μg FLAG-c17orf59-IRES-GFP or 1 
μg FLAG-GFP with 1 μg empty pRK5 in 10 cm culture plates as described above for 
signaling experiments. 24 hours after transfection, 300,000 cells were seeded per well on 
fibronectin-coated cover slips in 6-well plates. The following day cells were processed as 
described above and stained using anti-LAMP2 antibody at 1:400, anti-mTOR at 1:200, 
anti-RagC at 1:100, or anti-LAMTOR4 at 1:800.
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Images are max projections of 0.5 μm z-stacks. For MEF images, 5 slices were used; 10 
slices were used for HEK-293T images. Pearson’s correlation was calculated for the p18-
c17orf59 quantitation using ImageJ Coloc 2 plugin and analyzed using a Students two-tailed 
t-test.
Generation of CRISPR/Cas9 knockout cells
To generate c17orf59-null cells, guide RNAs were cloned into the pLentiCRISPR vector 
(Addgene) that was cut with BbsI (NEB #R0539). GuideRNAs were generated by annealing 
the following pairs of oligonucleotides and ligated into pLentiCRISPR:
Guide 1 fwd: caccGGGGCGGCCCGGGCCCGAGA
Guide 1 rev: aaacTCTCGGGCCCGGGCCGCCCC
Guide 2 fwd: caccgCAAAGTGGGTAAGGTCGCCG
Guide 2 rev: aaacCGGCGACCTTACCCACTTTGc
One million HEK-293E or 500,000 HeLa cells were seeded in 10cm culture dishes. 24 hours 
later, cells were transfected with 500 ng guideRNA plasmid with X-tremeGENE9. The 
following day, transfected cells were selected using puromycin. 48 hours after puromycin 
selection started, cells were re-transfected with guide RNA plasmid and allowed to grow to 
near confluence. 90% confluent dishes were trypsinized and single-cell sorted with a flow 
cytometer into the wells of a 96-well plate containing 150 μl of DMEM supplemented with 
30% IFS. Cells were grown until visible colonies were present, and the resultant colonies 
were trypsinized and expanded. Clones were validated for loss of the c17orf59 via 
immunoblotting.
Cholesterol depletion
Cells were depleted of cholesterol using a protocol modified from that described previously 
(Bartz et al., 2009). Briefly, 3 million HeLa cells were seeded in 10cm culture dishes. The 
following day, cells were washed twice in PBS and media was changed to either full DMEM 
with 10% IFS or DMEM containing 0.5% lipid depleted serum (LDS, Intracel #RP-056). 
Twenty-four hours later, cells were incubated with DMEM with 10% IFS, DMEM with 
0.5% LDS, or 2% 2-Hydroxypropyl)-β-cyclodextrin in DMEM with 0.5% LDS for 5 hours. 
Cells were lysed in 1ml Triton lysis buffer as described above.
c17orf59 cDNA cloning
c17orf59 cDNA was PCR amplified from HEK-293T cDNA using PlatinumTaq HIFI (Life 
Technology) the below gene-specific primers which have SalI and BamHI sites added at the 
5’ and 3’ ends, respectively. The PCR product was purified from a 1% agarose gel and 
digested with SalI and BamHI restriction endonucleases (NEB #R0138 and #R0136) 
overnight. The restriction product was gel purified and ligated into previously SalI-BamHI 
digested pRK5. For further subcloning, a NotI site present in the c17orf59 cDNA was 
mutated using overlapping PCR with the following primers, digested with SalI and NotI 
(NEB #R0189), and ligated into SalI-NotI-digested pRK5.
To amplify c17orf59 cDNA from HEK-293T, the following primers were used:
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Fwd: ACGCGTCGACGATGGAGTCGTCTCGGGGGCGG
Rev: CGCGGATCCTCACTTGCACAGGGCCTCCAA
To remove the internal NotI site and add SalI-NotI subcloning sites, the following primers 
were used:
Fwd1: caagtcgtcgacgATGGAGTCGTCTCGGGGGC
SDM1 rev: CGAGGAGGCTGCAGCGGGCAGC
SDM2 fwd: GCTGCCCGCTGCAGCCTCCTCG
Rev2: catgatgcggcccgcTCACTTGCACAGGGCCTCC
The 1000 nucleotides upstream of the c17orf59 gene locus were used as its endogenous 
promoter and amplified by PCR from genomic DNA from HEK-293T cells with the below 
primers and ligated to c17orf59 and pLEX-TRC202 plasmid cut with XmaI and BsrGI (NEB 
#R0180 and #R0575) by Gibson assembly (NEB #E5510). The ligation maintains the XmaI 
site upstream of the promoter, but eliminates the BsrGI site after the gene of interest.
To amplify the c17orf59 promoter the following primers were used:
Fwd: ccggctcgagggggcccgggCTTTCCAATGTCGCTGCACCATTGCATTTAG
Rev: catttccatACTGCAGGTGGGGGCCGC
To amplify FLAG-c17orf59 the following primers were used:
Fwd: cctgcagtATGGAAATGGACTACAAGGATGAC
Rev: gtctcgagttaggacttTCACTTGCACAGGGCCTC
To generate the FLAG-c17orf59-IRES-GFP construct, FLAG-c17orf59 cDNA was 
generated by PCR using a forward primer adding an NheI site and Kozak sequence to the 
FLAG-tag and the NotI-Rev2 primer described above, purified, and digested using NheI and 
NotI restriction endonucleases (NEB #R0131 and #RO189). Digested PCR produce was 
ligated into pCAGGS-PSAML141F, Y115F:GlyR-IRES-GFP (Addgene #32480) that had 
been digested with NheI and NotI to remove the insert.
To amplify FLAG-c17orf59 for cloning into pCAGGS-IRES-GFP the following primers 
were used:
Fwd: caagtccgtagcgccaccATGGAAATGGACTACAAGGATG
Rev: catgatgcggcccgcTCACTTGCACAGGGCCTCC
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• c17orf59 interacts with Ragulator, but not the Rag GTPases
• c17orf59 disrupts the Rag-Ragulator interaction in cells and in vitro
• c17orf59 overexpression inhibits mTORC1 and prevents its lysosomal 
recruitment
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Figure 1. 
c17orf59 is a Ragulator-interacting protein
A) c17orf59 binds Ragulator. Mass spectrometric analysis of anti-FLAG-
immunoprecipitates from HEK-293T cells stably-expressing FLAG-tagged HBXIP, a 
Ragulator subunit, or c17orf59. Data are presented as average unique peptide counts from 
two independent immunoprecipitations of HBXIP or c17orf59.
B) Recombinant c17orf59 co-immunoprecipitates Ragulator but not the Rag GTPases. 
Stably-expressed Ragulator subunit p14, c17orf59, or a control protein (Metap2) were 
immunoprecipitated from HEK-293T. Immunoprecipitates and whole cell lysates were 
analyzed by immunoblotting for the indicated proteins.
C) Recombinant Rag GTPases co-immunoprecipitate Ragulator, but not c17orf59. Anti-
FLAG immunoprecipitates and whole cell lysates from HEK-293T cells transiently 
expressing the indicated FLAG-tagged cDNA were analyzed by immunoblotting for the 
indicated proteins.
D) Ragulator, but not the Rag GTPases, binds c17orf59 in in vitro assays. Recombinant, 
HA-GST-tagged Ragulator, Rag dimer, or Rap2a (a control protein) were incubated with 
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20pmol purified, FLAG-tagged c17orf59. In lane 5, HA-GST-tagged Rag dimer was 
incubated with 20pmol FLAG-tagged Ragulator in addition to 20pmol FLAG-tagged 
c17orf59. Precipitates from glutathione affinity resin were immunoblotted for the indicated 
epitope tags. GST-Ragulator was expressed as HA-GST-p14, HA-MP1, -HBXIP, -c7orf59 
and p18-FLAG. FLAG-Ragulator was expressed as p18-FLAG, HA-p14, -MP1, -HBXIP, 
and -c7orf59.
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Figure 2. 
c17orf59 localizes to lysosomes with Ragulator
A) Recombinant c17orf59 localizes to lysosomes. p53-null MEFs were transfected with the 
HA-c17orf59 cDNA, immunostained with antibodies against LAMP1 (pseudocolored green) 
and the HA epitope tag (red), and imaged using confocal microscopy. Insets represent 
selected fields that have been magnified as well as the overlay of the fields. Scale bar 
represents 10 micrometers.
B) Recombinant c17orf59 co-localizes with p18. p18-null MEFs were transfected with the 
HA-c17orf59 and FLAG-p18 cDNA and processed and imaged as in (A), with p18 
pseudocolored red and the HA epitope tag pseudocolored green. Insets represent selected 
fields that have been magnified as well as the overlay of the fields. Scale bar represents 10 
micrometers.
C) Recombinant c17orf59 co-localizes with lysosomes in an amino acid-insensitive manner. 
p53-null MEFs were transfected with the HA-c17orf59 cDNA, starved for amino acids for 
60 minutes and stimulated with amino acids for 10 minutes. Cells were processed and 
imaged as in (A) and with antibodies against LAMP1 (pseudocolored green) and the HA 
epitope tag (red). Insets represent selected fields that have been magnified as well as the 
overlay of the fields. Scale bar represents 10 micrometers.
D) Recombinant c17orf59 co-localizes with lysosomes in serum-insensitive manner. p53-
null MEFs were transfected with the HA-c17orf59 cDNA, starved for amino acids for 60 
minutes and stimulated with amino acids for 10 minutes. Cells were processed and imaged 
as in (A). Insets represent selected fields that have been magnified as well as the overlay of 
the fields. Scale bar represents 10 micrometers.
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Figure 3. 
Loss of c17orf59 does not alter mTORC1 signaling in response to amino acids or insulin
A) c17orf59-null cells do not have alterations in amino acid-sensitive mTORC1 activity. 
c17orf59-null HEK-293E cells were generated by CRISPR/Cas9 technology. Cells were 
starved of amino acids for one hour and re-stimulated with amino acids for 10 minutes. 
Lysates were analyzed by immunoblotting for the indicated proteins.
B) c17orf59-null cells do not have alterations in growth factor-senstive mTORC1 activity. 
c17orf59-null HEK-293E cells were starved of serum for three hours and re-stimulated with 
insulin for 10 minutes. Lysates were analyzed as in (A)
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Figure 4. 
c17orf59 disrupts the Rag-Ragulator interaction
A) c17orf59 overexpression decreases the amount of Ragulator and Raptor recovered with 
immunoprecipitated Rags. Anti-FLAG immunoprecipitates and whole cell lysates from 
HEK-293T cells transfected with 100ng of the cDNAs encoding a FLAG-RagA/HA-RagC 
dimer or a control protein along with 1μg of HA-c17orf59 or a control protein were analyzed 
by immunoblotting for the indicated proteins.
B) c17orf59 overexpression decreases the amount of Rag and Raptor, but not Ragulator 
subunits, that interact with p14. Anti-FLAG immunoprecipitates and whole cell lysates from 
HEK-293T cells transfected with 100ng of the cDNAs encoding FLAG-p14 and HA-MP1 or 
a control protein along with 1μg HA-c17orf59 or a control protein were analyzed as in (A).
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C) Purified c17orf59 binds Ragulator in vitro and inhibits the Rag-Ragulator interaction. In 
vitro binding assay in which recombinant HA-GST Ragulator was pre-incubated with 
increasing quantities of purified FLAG-c17orf59 and followed by an incubation with 
purified FLAG-RagB/HA-RagC. For all samples in which FLAG-RagC/HA-RagB were 
used, 2μg (25 pmol) of Rag protein was added (lane 2, lanes 4-9). Similarly, 2μg of FLAG-
Rap2a protein as added in each marked sample (lane 10). The amount of FLAG-c17orf59 
protein added was as follows: 100ng (2.7 pmol, lane 5), 500ng (13.5 pmol, lane 6), 1μg (27 
pmol, lane 7), 5μg (135pmol, lane 8), and 10μg (270 pmol, lane 9 and all lanes marked with 
a “+”). The bar above each lane is to scale for c17orf59 protein added. Precipitates using 
glutathione affinity resin were analyzed by immunoblotting for indicated tagged proteins.
D) c17orf59 decreases the amount of Ragulator bound to Rags in vitro. In vitro binding 
assay in which purified HA-GST-RagB/HA-RagC was incubated with purified FLAG-
Ragulator and increasing amounts of purified FLAG-c17orf59. For all samples in which 
FLAG-Ragulator were used, 1μg (14 pmol) of Ragulator protein was added (lanes 3-7). 
Similarly, 2μg of FLAG-Rap2a protein as added in each marked sample (lane 3). The 
amount of FLAG-c17orf59 protein added was as follows: 100ng (2.7pmol, lane 5), 500ng 
(13.5pmol, lane 6), 1μg (27pmol, lane 7), 2μg (135pmol, lane 8 and all lanes marked with a 
“+”). The bar above each lane is to scale for c17orf59 protein added. Precipitates using 
glutathione affinity resin precipitates were analyzed as in (C).
E) c17orf59 overexpression decreases the amount of lysosomal RagC. HEK-293T cells were 
transfected with 1μg of the cDNA encoding FLAG-c17orf59-IRES-GFP (top panels) or 
FLAG-GFP controls (bottom panels). Cells were starved of amino acids for one hour and re-
stimulated with amino acids for 10 minutes, and immunostained with antibodies against 
RagC (pseudocolored red) and the LAMP1 (green) and imaged for GFP (white) using 
confocal microscopy. GFP-positive cells (third column) represent transfected cells.
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Figure 5. 
Overexpression of c17orf59 inhibits mTORC1
A) Overexpression of c17orf59 inhibits mTORC1 activity in cells. HEK-293T cells were 
transfected with 2 ng of the cDNA for FLAG-S6K1 as well as the increasing amounts of 
HA-c17orf59, HA-RagB-54L (GDP-bound mimetic), or control protein cDNAs. The 
amounts of HA-c17orf59 cDNA transfected are as follows: 500ng (lanes 5 and 6), and 2μg 
(lanes 7 and 8). FLAG immunoprecipitates and whole cell lysates were analyzed by 
immunoblotting for the indicated proteins.
B) c17orf59 overexpression decreases the amount of lysosomal mTOR. HEK-293T cells 
were transfected with 1μg of the cDNA encoding FLAG-c17orf59-IRES-GFP (top panels) 
or FLAG-GFP controls (bottom panels). Cells were starved of amino acids for one hour and 
re-stimulated with amino acids for 10 minutes, and immunostained with antibodies against 
mTOR (pseudocolored red) and the LAMP1 (green) and imaged for GFP (white) using 
confocal microscopy. GFP-positive cells (third column) represent transfected cells.
C) c17orf59 inhibits mTORC1 in cells with amino acid-insensitive mTORC1 signaling. 
HEK-293T cells stably expressing the RagB Q99L mutant (GTPase deficient; GTP-bound) 
or a control protein were transfected with a cDNA for FLAG-S6K1 and increasing amounts 
of the cDNA for HA-c17orf59 as in (A). The amounts of HA-c17orf59 cDNA transfected 
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are as follows: 500ng (lane 2), 1μg (lane 3) and 2μg (lane 4). The bar above each lane is to 
scale for c17orf59 cDNA added. Samples were analyzed as in (A).
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